Half dose ChAdOx1 nCoV-19 vaccine was equivalent to full doses to reduce moderate and severe COVID-19 cases

OBJECTIVES: Previously, we presented the effectiveness of ChAdOx1 nCoV-19 half-dose (HD) immunization for preventing new COVID-19 cases. Here, we evaluated the administration of an HD of ChAdOx1 nCoV-19 in the primary immunization protocol (up to two doses) in reducing moderate and severe cases, hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvão-Lima, Leonardo J., de Medeiros Júnior, Nésio Fernandes, Jesus, Galileu S., Morais, Antônio H.F., Caldeira-Silva, Gleyson J.P., Queiroz dos Santos, João Paulo, Rocha, Marcella, Marques dos Santos, Marquiony, Freire, Pierre A., Silva, Rodrigo D., Gouvea, Maria da Penha Gomes, Neto, Lauro Ferreira Pinto, Domingues, Carla Magda Allan Santos, Teixeira-Carvalho, Andréa, Martins-Filho, Olindo Assis, Valim, Valéria, Valentim, Ricardo A.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637913/
https://www.ncbi.nlm.nih.gov/pubmed/37953882
http://dx.doi.org/10.1016/j.ijregi.2023.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637913/
https://www.ncbi.nlm.nih.gov/pubmed/37953882
http://dx.doi.org/10.1016/j.ijregi.2023.09.007

Ejemplares similares